Trial Profile
A pilot, case-control study of oral rivaroxaban in acute deep vein thrombosis patients with permanent inferior vena cava filter
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Feb 2016
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- 01 Feb 2016 New trial record
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology